- Home
- AACT vs SRDX Comparison
AACT vs SRDX Comparison
Compare AACT & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AACT
- SRDX
- Stock Information
- Founded
- AACT 2021
- SRDX 1979
- Country
- AACT United States
- SRDX United States
- Employees
- AACT N/A
- SRDX N/A
- Industry
- AACT
- SRDX Medical/Dental Instruments
- Sector
- AACT
- SRDX Health Care
- Exchange
- AACT Nasdaq
- SRDX Nasdaq
- Market Cap
- AACT 677.5M
- SRDX 562.6M
- IPO Year
- AACT 2023
- SRDX 1998
- Fundamental
- Price
- AACT $10.91
- SRDX $39.19
- Analyst Decision
- AACT
- SRDX Hold
- Analyst Count
- AACT 0
- SRDX 4
- Target Price
- AACT N/A
- SRDX $43.00
- AVG Volume (30 Days)
- AACT 240.5K
- SRDX 225.2K
- Earning Date
- AACT 01-01-0001
- SRDX 11-06-2024
- Dividend Yield
- AACT N/A
- SRDX N/A
- EPS Growth
- AACT 48.19
- SRDX N/A
- EPS
- AACT 0.43
- SRDX N/A
- Revenue
- AACT N/A
- SRDX $126,078,000.00
- Revenue This Year
- AACT N/A
- SRDX $13.75
- Revenue Next Year
- AACT N/A
- SRDX $13.67
- P/E Ratio
- AACT $25.33
- SRDX N/A
- Revenue Growth
- AACT N/A
- SRDX N/A
- 52 Week Low
- AACT $10.35
- SRDX $25.17
- 52 Week High
- AACT $11.00
- SRDX $42.44
- Technical
- Relative Strength Index (RSI)
- AACT 60.62
- SRDX 63.68
- Support Level
- AACT $10.89
- SRDX $37.86
- Resistance Level
- AACT $10.95
- SRDX $39.26
- Average True Range (ATR)
- AACT 0.02
- SRDX 0.49
- MACD
- AACT 0.00
- SRDX 0.16
- Stochastic Oscillator
- AACT 57.89
- SRDX 96.70
About AACT Ares Acquisition Corporation II
Ares Acquisition Corp II is a blank check company.
About SRDX Surmodics Inc.
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.